Reference No |
4 |
5 |
6 |
7 |
8* |
9 |
10 |
11 |
Patients No |
45 |
25 |
58 |
28 |
28 |
77 |
58 |
49 |
Mean age |
47 |
38.6 |
|
40 |
NR |
46 |
29 |
37 |
M/F |
15/30 |
|
|
16-Dec |
16-Dec |
0/77 |
¼ |
18/31 |
IMT CC (mm) |
|
0.7 |
|
2.6 |
0.68 |
0.75 |
0.71 |
0.48 |
Plaque % |
35.6 |
8 |
9 |
|
53 |
|
21 |
11 |
Thrombotic ControlsNo |
40 |
|
|
|
26 |
|
|
49 |
Mean Age |
47 |
|
|
|
NR |
|
|
37 |
M/F |
15/25 |
|
|
|
|
|
|
18/31 |
IMT CC (mm) |
|
|
|
|
0.58 |
|
|
0.44 |
Plaque % |
35 |
|
|
|
|
|
|
5.8 |
Healthy Controls No |
|
40 |
89 |
28 |
38 |
77 |
58 |
49 |
Meanage |
|
42 |
|
41 |
NR |
47 |
29 |
37 |
M/F |
|
|
|
16-Dec |
|
0/77 |
4-Jan |
18/31 |
IMT CC (mm) |
|
0.61 |
|
1.2 |
0.58 |
0.64 |
0.59 |
0.41 |
Plaque % |
|
15 |
? |
|
|
|
3 |
5.8 |
Abbreviations: IMT: Intima Media Thickness; CC: Common
Carotid Artery; NR: Not Reported. Study No 8 included as controls a
mixture of patients with coronary artery disease and healthy subjects;
Study No 10 included patients with systemic lupus erythematosus.
Study No 7 used different parameters for IMT measurement. |